icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 13 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease

A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease

icon 2025-01-05
عنوان الدراسة
A Phase 2/3 Randomized, Multicenter Study of Osivelotor Administered Orally to Participants with Sickle Cell Disease and an Open-Label Pharmacokinetics Study in Pediatric Participants with Sickle Cell Disease
داعم الدراسة
Global Therapeutics Inc
دواء الدراسة
Osivelotor
رقم بروتوكول الدراسة
C5351004 (GBT021601)
حالة الدراسة
Ongoing
موقع الدراسة
Prince Mohammad Bin Naser Hospital (Jazan), King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
2/3
Comments and Suggestions

Comments and Suggestions

For any inquiries or comments about the government services, please fill in the required information.

Last update date: 05/01/2025 at 10:34 AM Saudi Arabia time